FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

418088004: Dibromopropamidine isethionate (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2014. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2573211010 Dibromopropamidine isethionate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2576482019 Dibromopropamidine isethionate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Dibromopropamidine isethionate Is a Dibrompropamidine (substance) false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Dibrompropamidine isethionate adverse reaction Causative agent (attribute) False Dibromopropamidine isethionate Inferred relationship Some
    Dibrompropamidine isethionate allergy Causative agent (attribute) False Dibromopropamidine isethionate Inferred relationship Some
    Product containing precisely dibrompropamidine isetionate 1.5 milligram/1 gram conventional release eye ointment (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dibromopropamidine isethionate Inferred relationship Some
    Dibrompropamidine isethionate 0.1% eye drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dibromopropamidine isethionate Inferred relationship Some
    Dibrompropamidine isetionate 1.5 mg/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dibromopropamidine isethionate Inferred relationship Some
    Dibromopropamidine isethionate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dibromopropamidine isethionate Inferred relationship Some
    Product containing calamine and dibrompropamidine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dibromopropamidine isethionate Inferred relationship Some
    Product containing dibrompropamidine and undecylenic acid (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Dibromopropamidine isethionate Inferred relationship Some
    Dibrompropamidine isethionate allergy Causative agent (attribute) False Dibromopropamidine isethionate Inferred relationship Some 1

    Reference Sets

    Concept inactivation indicator reference set

    GB English

    US English

    SAME AS association reference set (foundation metadata concept)

    Back to Start